tirzepatide breastfeeding safety and breastfeeding: New research offers hope for postpartum moms tirzepatide while nursing What Medications

INTRODUCTION Tirzepatide is a dual glucagon-like pedtide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) agonist and is primarily used to improve glycemic control along with weight reduction

Missed doses or improper form might mitigate weight loss advantages

Your clinician will decide whether a GLP-1 is appropriate and which formulation makes sense for you

Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)

Furthermore, DPP-IV inhibitors are not known to increase body weight